Biosynthesis specialist and Narcan ingredient maker Antheia reels in $56M in series C funding
Antheia, a biomanufacturer that makes a key ingredient for the opioid overdose treatment Narcan, reeled in $56 million in series C financing it said will be used to expand manufacturing operations in the U.S. and to start new programs in Singapore.
Antheia, a biomanufacturer that makes a key ingredient for the opioid overdose treatment Narcan, reeled in $56 million in series C financing it said will be used to expand manufacturing operations in the U.S. and to start new programs in Singapore.
